724 related articles for article (PubMed ID: 19479206)
1. Expanding and converting regulatory T cells: a horizon for immunotherapy.
Khattar M; Chen W; Stepkowski SM
Arch Immunol Ther Exp (Warsz); 2009; 57(3):199-204. PubMed ID: 19479206
[TBL] [Abstract][Full Text] [Related]
2. The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats.
Huang LF; Yao YM; Zhang LT; Dong N; Yu Y; Sheng ZY
Shock; 2009 Mar; 31(3):322-9. PubMed ID: 18665051
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of peripheral tolerance and immune regulation mediated by Treg.
Sakaguchi S; Wing K; Yamaguchi T
Eur J Immunol; 2009 Sep; 39(9):2331-6. PubMed ID: 19662638
[TBL] [Abstract][Full Text] [Related]
4. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?
Curotto de Lafaille MA; Lafaille JJ
Immunity; 2009 May; 30(5):626-35. PubMed ID: 19464985
[TBL] [Abstract][Full Text] [Related]
5. Revisiting regulatory T cells in type 1 diabetes.
Zhang Y; Bandala-Sanchez E; Harrison LC
Curr Opin Endocrinol Diabetes Obes; 2012 Aug; 19(4):271-8. PubMed ID: 22732485
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
7. CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cells.
Duggleby RC; Shaw TN; Jarvis LB; Kaur G; Gaston JS
Immunology; 2007 May; 121(1):129-39. PubMed ID: 17425604
[TBL] [Abstract][Full Text] [Related]
8. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other.
Horwitz DA; Zheng SG; Gray JD
Trends Immunol; 2008 Sep; 29(9):429-35. PubMed ID: 18676178
[TBL] [Abstract][Full Text] [Related]
9. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.
Hoffmann P; Boeld TJ; Eder R; Huehn J; Floess S; Wieczorek G; Olek S; Dietmaier W; Andreesen R; Edinger M
Eur J Immunol; 2009 Apr; 39(4):1088-97. PubMed ID: 19283780
[TBL] [Abstract][Full Text] [Related]
10. Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells.
Huber S; Stahl FR; Schrader J; Lüth S; Presser K; Carambia A; Flavell RA; Werner S; Blessing M; Herkel J; Schramm C
J Immunol; 2009 Apr; 182(8):4633-40. PubMed ID: 19342638
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
12. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.
Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB
J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865
[TBL] [Abstract][Full Text] [Related]
13. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
14. Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.
Schabowsky RH; Madireddi S; Sharma R; Yolcu ES; Shirwan H
Curr Opin Investig Drugs; 2007 Dec; 8(12):1002-8. PubMed ID: 18058571
[TBL] [Abstract][Full Text] [Related]
15. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of foxp3+ T regulatory cell-mediated suppression.
Shevach EM
Immunity; 2009 May; 30(5):636-45. PubMed ID: 19464986
[TBL] [Abstract][Full Text] [Related]
17. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.
Nishioka T; Nishida E; Iida R; Morita A; Shimizu J
Immunol Lett; 2008 Dec; 121(2):97-104. PubMed ID: 18930767
[TBL] [Abstract][Full Text] [Related]
18. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells and asthma.
Robinson DS
Clin Exp Allergy; 2009 Sep; 39(9):1314-23. PubMed ID: 19538496
[TBL] [Abstract][Full Text] [Related]
20. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]